Willingness to pay for one quality-adjusted life year in Iran.
Najmeh MoradiArash RashidianShirin NosratnejadAlireza OlyaeemaneshMarzieh ZanganehLeila ZareiPublished in: Cost effectiveness and resource allocation : C/E (2019)
From the general public's perspective, the monetary value of QALY for mild to severe diseases with no risk of death was less than one GDP per capita. Therefore, the obtained valuation range is recommended as reference only for the adoption of interventions designed to improve quality of life. Future studies should estimate the threshold of interventions for life-threatening diseases or formulate transparent policies in such contexts.